Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments
NCT ID: NCT06370572
Last Updated: 2026-01-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
714 participants
INTERVENTIONAL
2024-08-19
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Cognitive Empathy Training on Dementia Caregivers
NCT06650527
ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care
NCT06079203
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
NCT07032350
Intervention to Promote Advance Care Planning for Older Adults in the Emergency Department
NCT03402763
Pain With Dementia
NCT06854718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Pain in Advance Dementia (PAINAD) Score is a behavioral score based on observation of the person. The score depends on observation of five behaviors, breathing, negative vocalizations, facial expressions, body language, and consolability. Each observed behavior is scored from zero = none, to two = most, for a total score from zero to ten.
The design is an interrupted time series intervention, which allows a pre- and post-intervention assessment of the effect of PAINAD scale. Pre-intervention data from most immediate year to date prior to the intervention start defines the baseline state. The intervention, the EHR prompt to document the PAINAD first on patient arrival to the ED treatment area, and second one hour after delivery of first pain treatment. Prospective evaluation of EHR data will be used to evaluate use of the PAINAD.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-implementation
PLWD presenting to the ED with reported hip pain in the year preceding implementation of the PAINAD EHR prompt
No interventions assigned to this group
Post-implementation
PLWD presenting to the ED with reported hip pain in the 10 months following implementation of the PAINAD EHR prompt
PAINAD EHR Prompt
Implementation of PAINAD EHR prompt in the ED workflow for PLWD presenting to the ED with hip pain
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PAINAD EHR Prompt
Implementation of PAINAD EHR prompt in the ED workflow for PLWD presenting to the ED with hip pain
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ED arrival complaint of hip pain
* History of dementia by past medical history or problem list in EHR
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of North Carolina, Chapel Hill
OTHER
University of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teresita M Hogan, MD
Role: PRINCIPAL_INVESTIGATOR
University of Chicago
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chicago
Chicago, Illinois, United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIRB23-1162
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.